Yoo, S
Garg, E
Elliott, LT
Hung, RJ
Halevy, AR
Brooks, JD
Bull, SB
Gagnon, F
Greenwood, CMT
Lawless, JF
Paterson, AD
Sun, L
Zawati, MH
Lerner-Ellis, J
Abraham, RJS
Birol, I
Bourque, G
Garant, J-M
Gosselin, C
Li, J
Whitney, J
Thiruvahindrapuram, B
Herbrick, J-A
Lorenti, M
Reuter, MS
Adeoye, OO
Liu, S
Allen, U
Bernier, FP
Biggs, CM
Cheung, AM
Cowan, J
Herridge, M
Maslove, DM
Modi, BP
Mooser, V
Morris, SK
Ostrowski, M
Parekh, RS
Pfeffer, G
Suchowersky, O
Taher, J
Upton, J
Warren, RL
Yeung, RSM
Aziz, N
Turvey, SE
Knoppers, BM
Lathrop, M
Jones, SJM
Scherer, SW
Strug, LJ https://orcid.org/0000-0003-0503-9740
Funding for this research was provided by:
Genome Canada
Innovation, Science and Economic Development Canada
PHAC (2021-HQ-000051)
FRQ-S
Génome Québec
Canadian Institutes of Health Research (GA4-177739, MM1-181123, 447643, VR4-172753, 461170, 461304)
COVID-19 Immunity Task Force
Ministry of Colleges and Universities
Genome Alberta (RRP2)
Alberta Children’s Hospital
Mitogen DX
SickKids Foundation
University of Toronto (508791)
Genome British Columbia (COV199)
Southeastern Ontario Academic Medical Organization
Providence Healthcare Research Institute
CFI (HSC0005268/6220200122)
Hotchkiss Brain Institute, University of Calgary
Cumming School of Medicine, University of Calgary
Article History
Received: 15 June 2022
Accepted: 22 February 2023
First Online: 2 May 2023
Declarations
:
: HostSeq was approved by the Research Ethics Board of the Hospital for Sick Children (lead site) (#1000070720 from 2020-present). Written informed consent was obtained from all participants or parents/guardians/substitute decision makers prior to inclusion in the study.Additional REB information from the participating PIs:
: Not applicable.
: The authors declare that they have no competing interests.